Exploring the joint potential of inflammation, immunity, and receptor-based biomarkers for evaluating ME/CFS progression

DiscussionThe association between inflammatome and immunome markers is a candidate for controlled clinical study of ME/CFS progression markers that could be used for treatment individualization. Thus, the coupling effects between inflammation and immunity are potentially beneficial for the identification of prognostic factors in the context of ME/CFS progression mechanism studies.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research